A Deep Learning Model to Identify Mitral Valve Prolapse From the Echocardiogram A deep learning model identifies MVP from echocardiogram videos, and model predictions are associated with clinical endpoints including MR and future MVR @JACCJournals @ACCinTouch @ASE360

Thanks Dr. @SabhaBhatti for being a #CardioObstetrics trailblazer and sharing your insights. Read more from Dr. Bhatti in #JACC on use of POCUS for #CVD during pregnancy in LMICs. ➡️ https://t.co/OnAoMv3Zqv #ACCCardioOB @JACCJournals

Don’t let the Blue Jays bats distract you from the their defense! Presented by @NutrafolMen

Top 10 @ACCinTouch initiatives beautifully explained by @Drroxmehran at ‘Top Ten Topics in Clinical Cardiology’!!#ACCEarlyCareer #ACCIC #ACCWIC #ACCFIT @SCAI @scaiwin #CardioX @DLBHATTMD And it also happens to be Dr. Mehran’s bday today- wish you a very happy bday!! 🍰🎊🥂

ICYMI: This #JACCCardioOnc study offers a platform to functionally validate DIC-associated genes, aiding future research on variant associations and cardioprotective drug targets. https://t.co/oPtLNllfsV #cvGenetics #CardioOnc @pwburridge

In #AHF hospitalizations, women received lower loop diuretic doses, had less weight loss, and showed slightly lower diuretic response vs men, despite similar outcomes. Early WRF was more frequent in women and linked to worse 180-day outcomes. https://t.co/FrwWjB0u0L #JACCHF

Everyone deserves a world without impaired driving. Learn how Waymo is working to make our roads safer.

Statin efficacy to decrease #MACE depends on #CAD phenotypes and increases with the extent and severity of disease and in the presence of high-risk plaques. Patients without CAD have no benefit from statin therapy regarding MACE. https://t.co/OUpvgkgOBv #JACCIMG #cvCAD

Patients w/ mixed shock requiring VA-ECLS have a high mortality. Pts w/ mixed shock receiving higher support at 24hrs had a trend toward increased survival to discharge vs those w/ lower support. https://t.co/4vhzqMLeub #JACCAdvances

3️⃣ newly published studies in @JACCJournals examine 🗝️ aspects of HF: a multi-level polypill strategy for patients w/ #HFrEF; the impact of #HFpEF on individuals w/ #AFib; & the incidence of HF among adults w/ chronic kidney disease. More: https://t.co/tfN4ufJAba #HeartFailure

🌍 1 in 4 people globally are South Asian, yet only 3.2% are represented in major #CVD trials. Greater inclusion is crucial in addressing this high-risk population. ❤️‍🩹 https://t.co/rKwBDuOryR #JACCAsia #HealthEquity #ClinicalTrials @pnatarajanmd @NishantUppal7 @DLBHATTMD

A conversation with Bob Carr

Myocardial bridging, often in the mid- to distal LAD, can cause ischemia or arrhythmias under stress. Once thought benign, its impact depends on bridge depth, length, and location. Accurate anatomical and functional assessment is essential https://t.co/3iztduVrdC #JACCCaseReports

Dysfunctional mechanosensing through focal adhesions (FAs) is a driver of thoracic aortic disease in the β-aminopropionitrile mouse model, through activation of FA kinase and downstream activation Rho/ROCK and mTOR signaling. https://t.co/V7XYLEe9OW #JACCBTS

This #JACC viewpoint agrees that dysfunctional adipose tissue is crucial to #HFpEF disease pathogenesis, and yet sex-based differences highlight that the #adipokine framework is only one piece of the puzzle: there is more to HFpEF than just fat alone. https://t.co/O6eWVlM0VW

Clonal hematopoiesis is common and its CV implications increasingly clear. In our @JACCardioOnc primer, we share our approach to the CV evaluation and management of individuals with CH. Great working with Dr. Libby and team.

Long night at the office. Remember to stay hydrated. Don’t die 🕳️

After decades of disappointment in HFpEF, a new idea is shaking things up. Could heart failure with preserved EF actually be an adipose-driven disease? JACC’s latest issue explores “The Adipokine Hypothesis.” @JACCJournals 🔗 https://t.co/uy3fbcwzk6

The dx & tx of ICI myocarditis in #cardioonc is always humbling given its myriad, challenging presentations. ...but 🥸 as a #brugada phenocopy? @DOM_UCLA @AlexTalishinsky @UCLAHealthJCCC & our #Epeeps report/🔎this mysterious case in #JACCCaseReports! https://t.co/5RWz5QcSHX

In a subanalysis of DELIVER, #dapagliflozin reduces risk of CV death or worsening HF events in patients with #HFimpEF irrespective of degree of #LVEF improvement prior to enrollment. https://t.co/FRhU5zOnMP #JACCHF @rudolf_deboer @texhern @mvaduganathan @mapabonp

A twin born at 33 4/7 weeks (1.74 kg) with growth restriction and prenatal TOF/PS, possible absent PDA. PGE started soon after birth; transferred to NICU with sats >90% on room air. https://t.co/Fa4dIKKyq8 #JACCCaseReports #RVOT @conniejchoi

Strong evidence links dysfunctional adiposity to #HFpEF; however, current assessment tools are underutilized. Multidimensional frameworks integrating imaging, biomarkers, and body composition measures are needed. https://t.co/u8iENWPTjg #JACC @JLHarrington_MD @NutritionHF

In this #JACCINT state-of-the-art review, read about choosing the right alternative access for #TAVR, balancing feasibility, safety & efficacy. https://t.co/ase6u9u5d6 #CardioX @thiele_holger @fjsawaya @KendraGrubb @Mo_A_W

The physical exam changes & evolves but always remains critical to the clinical assessment of a patient. Check out our novel #POCUS protocol to assess volume status #jacchf @JACCJournals 👀 https://t.co/uujYGEuO8p